Skip to main content
Premium Trial:

Request an Annual Quote

Stratos Biosystems Develops Protein Chip for Cancer Biomarker Research; Looks for Collaborators

NEW YORK (GenomeWeb News) — Stratos Biosystems said Monday that it has completed pilot production capability for a new protein chip technology that could be used in biomarker-discovery programs for early cancer detection.
Stratos said its EC-Affinity chips for MALDI mass spectrometry are designed to give researchers a high-throughput affinity chromatography tool that is based on a new “self-assembling surface chemistry.”
The biochip technology will be used to detect “extremely rare proteins,” Stratos said, and will address what it calls a “major problem of lack of capacity and functionality” in detecting cancer-related proteins.
The company said it is now actively seeking new collaborators and partners.
Stratos has been funded by numerous groups and individuals, including its chief scientist Mark Stolowitz. In 2001 Stolowitz left Bothell, Wash., protein chip technology company Prolinx, where he was chief technology officer, to become vice president of biochip technologies at Lumicyte.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.